stoxline Quote Chart Rank Option Currency Glossary
  
Yield10 Bioscience, Inc. (YTEN)
0.25  0.001 (0.44%)    11-29 10:46
Open: 0.261
High: 0.261
Volume: 50,797
  
Pre. Close: 0.2489
Low: 0.245
Market Cap: 3(M)
Technical analysis
2023-11-29 10:20:43 AM
Short term     
Mid term     
Targets 6-month :  0.36 1-year :  0.43
Resists First :  0.3 Second :  0.37
Pivot price 0.25
Supports First :  0.2 Second :  0.17
MAs MA(5) :  0.24 MA(20) :  0.26
MA(100) :  0.68 MA(250) :  1.89
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  37.2 D(3) :  31.1
RSI RSI(14): 45.2
52-week High :  4.19 Low :  0.2
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
[ YTEN ] has closed below upper band by 44.9%. Bollinger Bands are 77.4% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 62 bars. This is a sign that the market may be about to initiate a new trend.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 0.25 - 0.25 0.25 - 0.25
Low: 0.22 - 0.22 0.22 - 0.22
Close: 0.25 - 0.25 0.25 - 0.25
Company Description

Yield10 Bioscience, Inc., an agricultural bioscience company, engages in developing technologies to enable step-change increases in crop yield in the United States and Canada. The company, through its Trait Factory, a trait gene discovery platform develops enhanced oilseed Camelina sativa for the production of proprietary seed products; and discovers high value genetic traits for the agriculture and food industries. Yield10 Bioscience, Inc. has license agreements with GDM Seeds; J. R. Simplot; Forage Genetics International, LLC; and Bayer AG. The company was formerly known as Metabolix, Inc. and changed its name to Yield10 Bioscience, Inc. in January 2017. Yield10 Bioscience, Inc. was incorporate in 1992 and is headquartered in Woburn, Massachusetts.

Headline News

Tue, 28 Nov 2023
Why SpringWorks Shares Are Trading Higher By Around 14%; Here ... - Investing.com UK

Mon, 27 Nov 2023
Yield10 Bioscience (YTEN) Price Target Increased by 23.53% to 3.57 - Nasdaq

Thu, 16 Nov 2023
Yield10 Bioscience, Inc. (NASDAQ:YTEN) Q3 2023 Earnings Call Transcript - Yahoo Finance

Tue, 31 Oct 2023
Yield10 Bioscience and BioMar Aim to Grow Fish Oil on Land - Yahoo Finance

Wed, 18 Oct 2023
Yield10 Bioscience Exercises Option to Finalize an Exclusive ... - BioSpace

Wed, 11 Oct 2023
Yield10 Bioscience Provides Update on Recent Advancements in ... - BioSpace

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Outperform
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Underperform
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Outperform
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Underperform
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Underperform
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Outperform
Stock Basics & Statistics
Exchange:
NASDAQ
Sector:
Basic Materials
Industry:
Agricultural Inputs
Shares Out 0 (M)
Shares Float 12 (M)
Held by Insiders 1.093e+007 (%)
Held by Institutions 18.1 (%)
Shares Short 131 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS -1.409e+007
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin -9 %
Return on Assets (ttm) 778.2 %
Return on Equity (ttm) -103.8 %
Qtrly Rev. Growth 147000 %
Gross Profit (p.s.) 0
Sales Per Share -205.83
EBITDA (p.s.) -3.94595e+006
Qtrly Earnings Growth -2.4 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow -11 (M)
Stock Valuations
PE Ratio -0.01
PEG Ratio 0
Price to Book value 0
Price to Sales -0.01
Price to Cash Flow 16.03
Stock Dividends
Dividend 0
Forward Dividend 130040
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android